GLP-1 Receptor Agonists In Research: Semaglutide, Tirzepatide, And Retatrutide

By Pep Nation Lab Research Desk··6 Min Read

The incretin-mimetic peptides are among the most studied research compounds in metabolic science. This guide gives a research-context overview of the class - what a GLP-1 receptor agonist is, how single- versus multi-receptor compounds differ, and the compounds most commonly referenced in the literature. It contains no dosing or human-use guidance.

What A GLP-1 Receptor Agonist Is

GLP-1 (glucagon-like peptide-1) is an incretin hormone involved in glucose-dependent signaling. A GLP-1 receptor agonist is a compound that binds and activates the GLP-1 receptor. In research, these compounds are studied as tools for investigating metabolic and energy-balance pathways.

Single Versus Multi-Receptor Compounds

Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual agonist that acts at both the GIP and GLP-1 receptors. Retatrutide is studied as a triple agonist adding glucagon-receptor activity. Moving from single to multi-receptor activity is a central theme in the current research literature on this class.

  • Semaglutide: GLP-1 receptor agonist.
  • Tirzepatide: dual GIP / GLP-1 receptor agonist.
  • Retatrutide: triple GIP / GLP-1 / glucagon receptor agonist (research stage).

How The Class Is Studied

In a research setting these compounds are handled as reference agonists for receptor-signaling and metabolic-pathway studies. As with all research peptides, they are for in vitro laboratory research only and are not for human or animal use.

Research Use Only: This guide is informational and describes research-context handling of compounds intended strictly for in vitro laboratory research. Products are not for human or animal consumption, ingestion, or injection, and are not FDA-approved. Nothing here is medical, clinical, or dosing advice.

Frequently Asked Questions

What is a GLP-1 receptor agonist?

GLP-1 (glucagon-like peptide-1) is an incretin hormone involved in glucose-dependent signaling. A GLP-1 receptor agonist is a compound that binds and activates the GLP-1 receptor, studied as a tool in metabolic research.

How do Semaglutide, Tirzepatide, and Retatrutide differ?

Semaglutide is a GLP-1 receptor agonist, Tirzepatide is a dual GIP/GLP-1 agonist, and Retatrutide is studied as a triple GIP/GLP-1/glucagon agonist. Moving from single to multi-receptor activity is a central theme in the class.

Are GLP-1 research compounds for human use?

No. Supplied as research peptides, they are for in vitro laboratory research only and are not for human or animal use.

Compounds Referenced In This Guide